Location: Palo Alto, CA
CIK: 0001839948 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 14, 2024
Total Value: $902M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GPCR | STRUCTURE THERAPEUTICS INC | 2,109,584 | $85.99M | 9.5% | $43.22 | — | ADRS | 86366E106 |
| — | INHIBRX,INC | 1,750,387 | $66.51M | 7.4% | $18.35 | — | COMM | 45720L107 |
| — | ICOSAVAX INC | 3,703,704 | $58.37M | 6.5% | $9.93 | — | COMM | 45114M109 |
| ANTX | AN2 Therapeutics, Inc. | 2,678,209 | $54.88M | 6.1% | $9.33 | +79.2% | COMM | 037326105 |
| — | RAYZEBIO, INC. | 869,908 | $54.08M | 6.0% | $22.20 | — | COMM | 75525N107 |
| — | AEROVATE THERAPEUTICS INC | 2,201,274 | $49.81M | 5.5% | $15.75 | — | COMM | 008064107 |
| GERN | GERON CORP | 23,375,839 | $49.32M | 5.5% | $1.89 | +3.1% | COMM | 374163103 |
| SVRA | SAVARA INC. | 10,000,000 | $47M | 5.2% | $3.56 | +7.5% | COMM | 805111101 |
| — | GRACELL BIOTECHNOLOGIES INC. | 4,514,786 | $45.33M | 5.0% | $5.22 | — | ADRS | 38406L103 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 179,917 | $41.63M | 4.6% | $110.42 | +58.5% | COMM | 558868105 |
| KALV | KALVISTA PHARMACEUTICALS, INC | 3,395,495 | $41.59M | 4.6% | $5.36 | +69.8% | COMM | 483497103 |
| SLN | SILENCE THERAPEUTICS PLC | 2,104,875 | $36.56M | 4.1% | $10.03 | — | ADRS | 82686Q101 |
| CMPS | COMPASS PATHWAYS PLC | 3,858,000 | $33.76M | 3.7% | $7.40 | — | ADRS | 20451W101 |
| COGT | COGENT BIOSCIENCES INC | 5,631,042 | $33.11M | 3.7% | $9.54 | -19.7% | COMM | 19240Q201 |
| TYRA | TYRA BIOSCIENCES INC | 1,989,103 | $27.55M | 3.1% | $12.71 | +1.9% | COMM | 90240B106 |
| — | TOURMALINE BIO INC | 1,007,902 | $26.39M | 2.9% | $26.18 | — | COMM | 89157D105 |
| TARS | TARSUS PHARMACEUTICALS, INC. | 1,142,857 | $23.14M | 2.6% | $17.70 | -5.6% | COMM | 87650L103 |
| DYN | DYNE THERAPEUTICS, INC | 1,650,150 | $21.95M | 2.4% | $12.99 | -24.8% | COMM | 26818M108 |
| KURA | KURA ONCOLOGY INC | 1,423,642 | $20.47M | 2.3% | $14.54 | -32.4% | COMM | 50127T109 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 2,040,816 | $16.24M | 1.8% | $6.47 | — | COMM | 152309100 |
| — | VISTAGEN THERAPEUTICS INC | 2,676,580 | $13.76M | 1.5% | $5.14 | — | COMM | 92840H202 |
| ABVX | Abivax SA | 1,100,000 | $11.77M | 1.3% | $10.70 | — | COMM | 00370M103 |
| CABA | CABALETTA BIO, INC | 486,795 | $11.05M | 1.2% | $3.64 | +361.8% | COMM | 12674W109 |
| TRDA | ENTRADA THERAPEUTICS INC | 584,955 | $8.827M | 1.0% | $17.12 | — | COMM | 29384C108 |
| NRIX | NURIX THERAPEUTICS INC | 717,654 | $7.406M | 0.8% | $6.85 | 0.0% | COMM | 67080M103 |
| CCCC | C4 THERAPEUTICS, INC. | 1,276,574 | $7.213M | 0.8% | $5.83 | -60.9% | COMM | 12529R107 |
| TSHA | TAYSHA GENE THERAPIES, INC. | 2,912,861 | $5.156M | 0.6% | $1.87 | +6.7% | COMM | 877619106 |
| VTYX | VENTYX BIOSCIENCES, INC | 815,724 | $2.015M | 0.2% | $29.94 | -68.3% | COMM | 92332V107 |
| KOD | KODIAK SCIENCES INC | 267,941 | $815K | 0.1% | $2.22 | 0.0% | COMM | 50015M109 |